Related Experiment Video
Updated: Jun 19, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and
Le Thi Kim Chung1, Toshio Hosaka, Masaki Yoshida
1Department of Nutrition and Metabolism, Institute of Health Biosciences, University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Abstract:
Exendin-4 (Ex-4) is a glucagon-like peptide-1 receptor (GLP-1R) agonist that has been used as a drug injected subcutaneously for treatment of type 2 diabetes. Many studies have revealed molecular targets of Ex-4, but its influence on adipokines has not been determined. Our study showed that Ex-4 induced secretion of adiponectin into the culture medium of 3T3-L1 adipocytes. This effect of Ex-4 is due to increased adiponectin mRNA level through the GLP-1R. Both forskolin and 3-isobutyl-1-methylxanthine (IBMX), which may finally elevate cyclic adenosine monophosphate (cAMP) concentration, prevented the induction of adiponectin expression by Ex-4. Moreover, H89, a protein kinase A inhibitor, blocked the effect of Ex-4 on adiponectin. On the other hand, Ex-4 decreased the mRNA levels of inflammatory adipokines. The results indicate that Ex-4 directly promotes adiponectin secretion via the protein kinase A pathway in 3T3-L1 adipocytes and may ameliorate insulin resistance.
Insights
Exendin-4 (Ex-4), a type 2 diabetes drug, boosts adiponectin secretion in fat cells via the glucagon-like peptide-1 receptor (GLP-1R) and protein kinase A pathway. It also reduces inflammatory adipokines, potentially improving insulin resistance.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Research
Background:
- Exendin-4 (Ex-4) is a glucagon-like peptide-1 receptor (GLP-1R) agonist used for type 2 diabetes.
- The impact of Ex-4 on adipokine secretion remains largely unexplored.
Purpose of the Study:
- To investigate the effect of Ex-4 on adipokine expression and secretion in 3T3-L1 adipocytes.
- To elucidate the molecular mechanisms underlying Ex-4's influence on adiponectin.
Main Methods:
- Treatment of 3T3-L1 adipocytes with Ex-4.
- Measurement of adiponectin mRNA and protein levels.
- Inhibition studies using forskolin, IBMX, and H89 to explore signaling pathways.
Main Results:
- Ex-4 significantly increased adiponectin secretion and mRNA levels in 3T3-L1 adipocytes.
- The Ex-4-induced adiponectin increase was mediated through the GLP-1R and the protein kinase A (PKA) pathway.
- Ex-4 decreased the mRNA levels of inflammatory adipokines.
- Forskolin, IBMX, and H89 inhibited the Ex-4-induced adiponectin expression.
Conclusions:
- Ex-4 directly stimulates adiponectin secretion in adipocytes via the PKA signaling pathway.
- Ex-4 may ameliorate insulin resistance by modulating adipokine profiles.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Dipeptidyl Peptidase 4 Inhibitors
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
